Risk of Mortality Following Catheter Ablation of Atrial Fibrillation

被引:103
作者
Cheng, Edward P. [1 ]
Liu, Christopher F. [1 ]
Yeo, Ilhwan [2 ]
Markowitz, Steven M. [1 ]
Thomas, George [1 ]
Ip, James E. [1 ]
Kim, Luke K. [1 ]
Lerman, Bruce B. [1 ]
Cheung, Jim W. [1 ]
机构
[1] New York Presbyterian Hosp, Weill Cornell Med, Div Cardiol, Dept Med,Weill Cornell Cardiovasc Outcomes Res Gr, New York, NY USA
[2] Icahn Sch Med Mt Sinai, Dept Med, New York, NY 10029 USA
关键词
atrial fibrillation; catheter ablation; early mortality; outcomes; UNITED-STATES; OUTCOMES;
D O I
10.1016/j.jacc.2019.08.1036
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BACKGROUND Although procedure-related deaths during index admission following catheter ablation of AF have been reported to be low, adverse outcomes can occur after discharge. There are limited data on mortality early after AF ablation. OBJECTIVES This study aimed to identify rates, trends, and predictors of early mortality post-atrial fibrillation (AF) ablation. METHODS Using the all-payer, nationally representative Nationwide Readmissions Database, we evaluated 60,203 admissions of patients 18 years of age or older for AF ablation between 2010 and 2015. Early mortality was defined as death during initial admission or 30-day readmission. Based on International Classification of Diseases-9th Revision, Clinical Modification codes, we identified comorbidities, procedural complications, and causes of readmission following AF ablation. Multivariable logistic regression was performed to assess predictors of early mortality. RESULTS Early mortality following AF ablation occurred in 0.46% cases, with 54.3% of deaths occurring during readmission. From 2010 to 2015, quarterly rates of early mortality post-ablation increased from 0.25% to 1.35% (p < 0.001). Median time from ablation to death was 11.6 (interquartile range [IQR]: 4.2 to 22.7) days. After adjustment for age and comorbidities, procedural complications (adjusted odds ratio [aOR]: 4.06; p < 0.001), congestive heart failure (CHF) (aOR: 2.20; p = 0.011) and low AF ablation hospital volume (aOR: 2.35; p = 0.003) were associated with early mortality. Complications due to cardiac perforation (aOR: 2.98; p = 0.007), other cardiac (aOR: 12.8; p < 0.001), and neurologic etiologies (aOR: 8.72; p < 0.001) were also associated with early mortality. CONCLUSIONS In a nationally representative cohort, early mortality following AF ablation affected nearly 1 in 200 patients, with the majority of deaths occurring during 30-day readmission. Procedural complications, congestive heart failure, and low hospital AF ablation volume were predictors of early mortality. Prompt management of post-procedure complications and CHF may be critical for reducing mortality rates following AF ablation. (C) 2019 by the American College of Cardiology Foundation.
引用
收藏
页码:2254 / 2264
页数:11
相关论文
共 21 条
  • [1] [Anonymous], 2019, JACC CLIN ELECTROPHY
  • [2] [Anonymous], INTR HCUP NAT READM
  • [3] [Anonymous], EUR HEART J
  • [4] [Anonymous], HCUP QUALITY CONTROL
  • [5] Updated Worldwide Survey on the Methods, Efficacy, and Safety of Catheter Ablation for Human Atrial Fibrillation
    Cappato, Riccardo
    Calkins, Hugh
    Chen, Shih-Ann
    Davies, Wyn
    Iesaka, Yoshito
    Kalman, Jonathan
    Kim, You-Ho
    Klein, George
    Natale, Andrea
    Packer, Douglas
    Skanes, Allan
    Ambrogi, Federico
    Biganzoli, Elia
    [J]. CIRCULATION-ARRHYTHMIA AND ELECTROPHYSIOLOGY, 2010, 3 (01) : 32 - 38
  • [6] Prevalence and Causes of Fatal Outcome in Catheter Ablation of Atrial Fibrillation
    Cappato, Riccardo
    Calkins, Hugh
    Chen, Shih-Ann
    Davies, Wyn
    Iesaka, Yoshito
    Kalman, Jonathan
    Kim, You-Ho
    Klein, George
    Natale, Andrea
    Packer, Douglas
    Skanes, Allan
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2009, 53 (19) : 1798 - 1803
  • [7] In-Hospital Complications Associated With Catheter Ablation of Atrial Fibrillation in the United States Between 2000 and 2010 Analysis of 93 801 Procedures
    Deshmukh, Abhishek
    Patel, Nileshkumar J.
    Pant, Sadip
    Shah, Neeraj
    Chothani, Ankit
    Mehta, Kathan
    Grover, Peeyush
    Singh, Vikas
    Vallurupalli, Srikanth
    Savani, Ghanshyambhai T.
    Badheka, Apurva
    Tuliani, Tushar
    Dabhadkar, Kaustubh
    Dibu, George
    Reddy, Y. Madhu
    Sewani, Asif
    Kowalski, Marcin
    Mitrani, Raul
    Paydak, Hakan
    Viles-Gonzalez, Juan F.
    [J]. CIRCULATION, 2013, 128 (19) : 2104 - 2112
  • [8] Ablation Versus Amiodarone for Treatment of Persistent Atrial Fibrillation in Patients With Congestive Heart Failure and an Implanted Device: Results From the AATAC Multicenter Randomized Trial
    Di Biase, Luigi
    Mohanty, Prasant
    Mohanty, Sanghamitra
    Santangeli, Pasquale
    Trivedi, Chintan
    Lakkireddy, Dhanunjaya
    Reddy, Madhu
    Jais, Pierre
    Themistoclakis, Sakis
    Dello Russo, Antonio
    Casella, Michela
    Pelargonio, Gemma
    Narducci, Maria Lucia
    Schweikert, Robert
    Neuzil, Petr
    Sanchez, Javier
    Horton, Rodney
    Beheiry, Salwa
    Hongo, Richard
    Hao, Steven
    Rossillo, Antonio
    Forleo, Giovanni
    Tondo, Claudio
    Burkhardt, J. David
    Haissaguerre, Michel
    Natale, Andrea
    [J]. CIRCULATION, 2016, 133 (17) : 1637 - 1644
  • [9] Atrioesophageal Fistula Clinical Presentation, Procedural Characteristics, Diagnostic Investigations, and Treatment Outcomes
    Han, Hui-Chen
    Ha, Francis J.
    Sanders, Prashanthan
    Spencer, Ryan
    Teh, Andrew W.
    O'Donnell, David
    Farouque, Omar
    Lim, Han S.
    [J]. CIRCULATION-ARRHYTHMIA AND ELECTROPHYSIOLOGY, 2017, 10 (11)
  • [10] Hosseini Seyed Mohammadreza, 2017, JACC Clin Electrophysiol, V3, P1240, DOI 10.1016/j.jacep.2017.05.005